Elution characteristics of doxorubicin-loaded microspheres differ by drug-loading method and microsphere size

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 3, 2011, Pages 361-368

  Kos, Sebastian ^a,b   Wasan, Ellen ^a,c   Weir, Graeme ^a   Reb, Philipe ^d   Cornell, Curt ^e   Ford, Jo Ann ^f   Liu, David M ^a,g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c BRITISH COLUMBIA INSTITUTE OF TECHNOLOGY   (Canada)

^d Research and Development Department   (France)

^e Biosphere Medical   (United States)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; MICROSPHERE; SUPERABSORBEN POLYMER MICROSPHERE; UNCLASSIFIED DRUG;

ARTICLE; DRUG BINDING SITE; DRUG RELEASE; ELUTION; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRATION; HYPOTHESIS; LOADING DRUG DOSE; PARTICLE SIZE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ABSORPTION; ACRYLATES; ANTIBIOTICS, ANTINEOPLASTIC; CHEMISTRY, PHARMACEUTICAL; CHEMOEMBOLIZATION, THERAPEUTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; MICROSPHERES; PARTICLE SIZE; POLYVINYL ALCOHOL; SOLUBILITY; SURFACE PROPERTIES; TIME FACTORS;

EID: 79952120957     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.11.032     Document Type: Article

References (21)

1. Taylor RR, Tang Y, Gonzalez MV, Stratford PW, Lewis AL. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 2007; 30:7-14. (Pubitemid 44908921)
2. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 2006; 17:1235-1249.
3. Kurihara N, Kikuchi K, Tanabe M, et al. Partial resection of the second portion of the duodenum for gastrointestinal stromal tumor after effective transarterial embolization. Int J Clin Oncol 2005; 10:433-437. (Pubitemid 41821529)
4. Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 2005; 104:1590-1602. (Pubitemid 41437421)
5. Satake M, Uchida H, Arai Y, et al. Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 2008; 31:756-761.
6. Marelli L, Stigliano R, Triantos C, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30:6-25. (Pubitemid 44900485)
7. Kalayci C, Johnson PJ, Raby N, Metivier EM, Williams R. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin. J Hepatol 1990; 11:349-353.
8. Johnson PJ, Kalayci C, Dobbs N, et al. Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol. J Hepatol 1991; 13:120-127.
9. Osuga K, Khankan AA, Hori S, et al. Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience. J Vasc Interv Radiol 2002; 13(9):929-934.
10. Osuga K, Hori S, Kitayoshi H, et al. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol 2002; 13:1125-1133. (Pubitemid 35332898)
11. Osuga K, Hori S, Hiraishi K, et al. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol 2008; 31:1108-1116.
12. Khankan AA, Osuga K, Hori S, Morii E, Murakami T, Nakamura H. Embolic effects of superabsorbent polymer microspheres in rabbit renal model: comparison with tris-acryl gelatin microspheres and polyvinyl alcohol. Radiat Med 2004; 22:384-390. (Pubitemid 40144015)
13. Grosso M, Melchiorre F, Pedrazzini F, et al. TACE with HepaSphere in treatment of unresectable HCC: preliminary results of a monocentric study and comparison with historical personal series of standard TACE. Lisbon: CIRSE; 2009; 281.
14. Roche A, Franco D, Dhumeaux D, Bismuth H, Doyon D. Emergency hepatic arterial embolization for secondary hypercalcemia in hepatocellular carcinoma. Radiology 1979; 133:315-316. (Pubitemid 10199126)
15. Yamada R, Nakatsuka H, Nakamura K, et al. Hepatic artery embolization in 32 patients with unresectable hepatoma. Osaka City Med J 1980; 26:81-96. (Pubitemid 11009683)
16. Vogl TJ, Naguib NN, Nour-Eldin NE, et al. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications. Eur J Radiol 2009; 72:505-516.
17. Bilbao JI, de Luis E, Garcia de Jalon JA, et al. Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation. J Vasc Interv Radiol 2008; 19:1625-1638.
18. Bastian P, Bartkowski R, Kohler H, Kissel T. Chemo-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy. Eur J Pharm Biopharm 1998; 46:243-254. (Pubitemid 29057670)
19. Kan Z, Ivancev K, Hagerstrand I, Chuang VP, Lunderquist A. In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol. 1989; 30:419-425.
20. Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007; 46:474-481. (Pubitemid 46201723)
21. van Malenstein H, Maleux G, Heye S, et al. A randomized phase II study of transarterial chemoembolisation with doxorubicin eluting hepaspheres in patients with hepatocellular carcinoma. Milan: ILCA; 2009; 113.